Answers are grounded in this paper and cite their sources.
We analyzed survival in 203 children with Philadelphia-chromosome-positive chronic myeloid leukemia (CML). Median survival was 4.1 years; average annual risk of death was 20%. These survival data are similar to those reported in adults. Because there is no possibility of long-term disease-free survival in children with CML with conventional therapies, the findings of this study suggest that bone marrow transplantation should be considered in these patients.
No takes yet. Share an insight, caveat, or question.
Marin et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: